Limit uncertainty with the enhanced MAYFIELD^®2 Cranial Stabilization System.

• High performance composite and cast aluminium coated components provide durable, rigid and reliable materials to withstand the decontamination process requirements.
• Resistant to wide range of pH detergents (pH from 3 to 11) in manual cleaning cycle.
• Withstand WHO (World Health Organization) protocol for infectious diseases decontamination.
• Autoclavable with high temperature from 132°C-134°C (-0/+3°C) from 3 to 18 minutes.
• Ease of handling & adjustments.
• Precise positioning.

MAYFIELD^®2 Base Unit – A3101 & MAYFIELD^®2 NARROW Base unit – A3100*

• Support device that facilitates attachment of skull clamps and headrests systems to the Operating Room (OR) table.
• No tool required for adjustment.
• Includes A3018 standard swivel adaptor to provide a complete set.
• Self locking lever provides added locking mechanism when the system is locked in place.

MAYFIELD^®2 Skull Clamp – A3059

• Design based on Modified Skull Clamp (A1059) to provide 3-point rigid cranial fixation.
• Only one hand needed to disengage and smoothly slide the rachet arm.
• Allows precision with skull clamp positioning:
  • Additional rocker arm positions for maximum access to the operative site.
  • Longer skull clamp uprights to better interface with patient’s facial anatomy.
  • 51% more ratcheting teeth for more precise and smaller increments when pushing together the two halves.
• Compatible with current MAYFIELD^® Skull pins.

MAYFIELD^®2 TriStar swivel adaptors – A3008

• Available for image-guided surgery procedures when ancillary components are required.

^{* All components are also sold separately.}

Indications

MAYFIELD^®2 Cranial Stabilization System is placed on the patient’s skull to hold their head and neck securely in a particular position when rigid fixation is desired.. The skull clamp is indicated for use in open and percutaneous craniotomies as well as spinal surgery when rigid fixation is necessary.

Contraindications

Do not use for other indications than the ones specified in the Instruction Manual.

---

Ordering Information

Integra LifeSciences Services (France) SAS
Immeuble Sequoia 2 • 97 allée Alexandre Borodine
Parc technologique de la Porte des Alpes
69800 Saint Priest • FRANCE
Phone: +33 (0)4 37 47 59 00 • fax: +33 (0)4 37 47 59 99
integralife.eu

---

Product Catalogues

---

Regulatory Information

Class I and IIa

Integra LifeSciences Corporation
4900 Charlemar Drive, Building A
Cincinnati • Ohio 45227 • USA

Integra LifeSciences Services (France) SAS
Immeuble Sequoia 2 • 97 allée Alexandre Borodine
Parc technologique de la Porte des Alpes
69800 Saint Priest • FRANCE
Phone: +33 (0)4 37 47 59 50 • fax: +33 (0)4 37 47 59 30

CE 0086

---

Legal information

Availability of these products might vary from a given country or region to another, as a result of specific local regulatory approval or clearance requirements for sale in such country or region.
• Always refer to the appropriate instructions for use for complete clinical instructions. Consult product labels and inserts for any indications, contraindications, hazards, warnings, precautions, and instructions for use
• Non contractual document. The manufacturer reserves the right, without prior notice, to modify the products in order to improve their quality.
• Warning: Applicable laws restrict these products to sale by or on the order of a physician.
Products mentioned in this document are CE class I and IIa devices. Please contact Integra customer service should you need any additional information on devices classification. All the medical devices mentioned on this document are CE marked according to European council directive 93/42/EEC on medical devices and its relatives, unless specifically identified as “NOT CE MARKED”.

Integra and the Integra logo are registered trademarks of Integra LifeSciences Corporation in the United States and/or other countries. Mayfield is a registered trademark of SM USA Inc and is used by Integra Lifesciences Corporation under license.
©2018 Integra LifeSciences Corporation. All rights reserved. Last revision date: 02/2018. 0835085-EN-1
DOCUMENT FOR USE IN EUROPE (EXCEPT FRANCE), MIDDLE-EAST and AFRICA ONLY